In such embodiments, the second stage of the invention will effect removal of leukocytes from the leukocyte depleted platelet-rich plasma.
The third stage of the invention will effect the reduction in volume of the leukocyte contaminated platelet-rich plasma to form the desired leukocyte depleted platelet concentrate.